Cogent Biosciences (COGT) Revenue: 2017-2020
Historic Revenue for Cogent Biosciences (COGT) over the last 4 years, with Dec 2020 value amounting to $7.9 million.
- Cogent Biosciences' Revenue fell 69.41% to $312,000 in Q3 2020 from the same period last year, while for Sep 2020 it was $23.2 million, marking a year-over-year increase of 110.23%. This contributed to the annual value of $7.9 million for FY2020, which is 65.02% down from last year.
- Cogent Biosciences' Revenue amounted to $7.9 million in FY2020, which was down 65.02% from $22.5 million recorded in FY2019.
- In the past 5 years, Cogent Biosciences' Revenue registered a high of $22.5 million during FY2019, and its lowest value of $7.9 million during FY2020.
- Its 3-year average for Revenue is $13.4 million, with a median of $9.7 million in 2018.
- In the last 5 years, Cogent Biosciences' Revenue spiked by 131.14% in 2019 and then plummeted by 65.02% in 2020.
- Yearly analysis of 4 years shows Cogent Biosciences' Revenue stood at $8.4 million in 2017, then grew by 16.44% to $9.7 million in 2018, then skyrocketed by 131.14% to $22.5 million in 2019, then tumbled by 65.02% to $7.9 million in 2020.